Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease
✍ Scribed by Farah Bokharaei-Salim; Hossein Keyvani; Seyed Hamid Reza Monavari; Seyed Moayed Alavian; Zahra Madjd; Mohssen Nassiri Toosi; Amir Houshang Mohammad Alizadeh
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 165 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The diagnosis of cryptogenic liver disease is made when after extensive evaluations, recognizable etiologies of chronic liver disease are excluded. In this study, the presence of hepatitis C virus (HCV) RNA was tested in peripheral blood mononuclear cells (PBMCs) taken from Iranian patients who although were found negative for plasma HCV RNA and anti‐HCV antibodies, suffered from chronic liver disease of unknown etiology. From September 2007 to March 2010, 69 patients from Tehran with chronic liver disease of unknown etiology who were referred to our center were enrolled in the present study. PBMCs were isolated from 10 mL peripheral blood specimens. HCV‐RNA status was tested in plasma and PBMCs samples by reverse‐transcription polymerase chain reaction (RT‐PCR). HCV‐RNA was detected in HCV‐positive PBMCs specimens by RT‐PCR method. HCV genotypes were subsequently analyzed in HCV‐positive samples using restriction fragment length polymorphism (RFLP) assay; then HCV genotypes were confirmed by sequencing of 5′ non‐coding fragments after cloning PCR products into pJET1.2/blunt cloning vector. HCV‐RNA was detected in PBMCs specimens belonging to 7 (10%) out of 69 patients. Genotyping of the HCV‐RNA isolated from PBMCs showed that 3 (43%) patients with occult HCV infection had genotype 1b, 2 (29%) had genotype 1a, and another 2 (29%) had genotype 3a. The results of this study suggest that patients with chronic liver disease of unknown etiology may have occult HCV infection in the absence of anti‐HCV antibodies and plasma HCV‐RNA. It has been suggested that in the absence of liver biopsy specimens, analysis of PBMC sample for HCV‐RNA would be informative. J. Med. Virol. 83:989–995, 2011. © 2011 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
To examine the prevalence of hepatitis G virus (HGV) in end-stage liver disease of unknown cause and the role of HGV infection in posttransplantation hepatitis, we studied 46 patients undergoing liver transplantation (mean age, 50 years; M:F, 18:28) with cryptogenic cirrhosis. HGV RNA was detected b
## Abstract The prevalence of antibody to hepatitis C virus (HCV) was studied in 207 patients with chronic liver disease of unknown etiology, in relation to clinical, epidemiological and histological features. Serum antibody to C‐100 epitope of HCV was detected by ELISA in 82.6% of patients, with a
## Abstract Although occult hepatitis B virus (HBV) infection (HBV‐DNA in serum in the absence of hepatitis B surface antigen [HBsAg]) is common in chronic hepatitis C, its characteristics are not well known. In this work, the presence of HBV‐DNA (by polymerase chain reaction; PCR) and its distribu
## Abstract Family members of patients with chronic hepatitis C virus (HCV) infection are at increased risk of HCV infection but the prevalence of HCV among family members of patients with occult HCV infection is not known. Anti‐HCV, serum HCV RNA and levels of liver enzymes were determined in 102
## Abstract The clinical and virological significance of low‐level viremia by hepatitis B virus (HBV) in hepatitis C virus (HCV)‐infected patients remains unclear. HBV‐DNA and HCV‐RNA were, therefore, quantitatively analyzed in livers and sera from co‐infected patients. HBV‐DNA and HCV‐RNA were qua